Alexion says “no” to investor proactive sale demand
FDA approves first copycats of Novartis MS drug Gilenya
$178M stockpile of Merck ebola vaccine authorized
Ipsen plunges as FDA halts bone drug trial for safety concerns
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
